Xylo-Mepha Plus
Xylo-Mepha Plus is a medicine authorised by Swissmedic under authorisation number 65868. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 26 August 2016 and the authorisation is valid without a time limit. ATC code R01AB06 places the medicine in the group Nasal preparations.
| Authorisation number | 65868 |
|---|---|
| Name | Xylo-Mepha Plus |
| Full name | Xylo-Mepha Plus, Nasenspray |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | D · No prescription, with advice |
| ATC code | R01AB06 |
| First authorisation | 26 August 2016 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Xylo-Mepha Plus, Nasenspray | D | 26 August 2016 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 10 | ml | R01AB06 | 12.02.2. | D |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Xylo-Mepha Plus authorised in Switzerland?
Yes. Xylo-Mepha Plus is authorised by Swissmedic under authorisation number 65868, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Xylo-Mepha Plus have?
Xylo-Mepha Plus is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.
Who is the authorisation holder of Xylo-Mepha Plus?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.